Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Roger Jeffs currently holds 58,367 shares of UNITED THERAPEUTICS Corp (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roger Jeffs has been a net seller of UTHR stock. They have purchased $2.6M and sold $210.7M worth of shares.
Roger Jeffs's most recent insider trade was on Jun 11, 2026, when they sold 286 shares at $249.12 per share.
Roger Jeffs serves as Executive at UNITED THERAPEUTICS Corp (UTHR). They have executed 736 insider transactions totaling $213.3M over their tenure at the company.
Roger Jeffs holds the position of Executive at UNITED THERAPEUTICS Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Roger Jeffs has shown a selling trading pattern, with $2.6M in total purchases and $210.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Roger Jeffs was on Aug 27, 2025, when they sold $2.4M worth of AXSM shares. This transaction involved 20,000 shares at $122.30 per share.
Roger Jeffs currently owns 58,367 shares of UNITED THERAPEUTICS Corp (UTHR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Roger Jeffs's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Roger Jeffs has 736 Form 4 filings on record as an insider at UNITED THERAPEUTICS Corp.
Set alerts for Roger Jeffs and 40,000+ other insiders.